$9.99
Explore the FDA’s strategic move to classify Zika virus serological reagents as class II with special controls. This course details the regulatory implications, safety assurances, and potential benefits in patient access to diagnostic tools, providing learners with essential insights into the impact of this classification on the healthcare landscape.
In this course you will learn the following:
* Understand the classification process and criteria for Zika virus serological reagents.
* Identify the special controls and general controls applicable to these devices.
* Recognize the impact of this classification on regulatory burdens and patient access to innovative devices.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, learners may miss crucial insights into the regulatory processes and special controls that ensure the safety and effectiveness of Zika virus serological reagents, potentially impacting their understanding of these devices’ market accessibility.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the Zika Virus Serological Reagents.
Key regulatory references include:
Course SKU
FR-25-1360-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare Program; Updates to the Master List of Items Potentially Subject to Face to Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List. Document Number: 2026-00487
Buy this Course
FR-26-1672-1
Why This Course is Important
Missing this course could result in denied claims, costly audits, and compliance failures that disrupt patient access and jeopardize Medicare reimbursements.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare Program; Updates to the Master List of Items Potentially Subject to Face to Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List.
Key regulatory references include:
Course SKU
FR-26-1672-1
© 2026 CourseAvenue, LLC | All rights reserved.
